Evaluation of the Roche Cobas TaqScreen Multiplex V 2.0 Test for Blood Screening: A Saudi Arabian Study

Author(s): AL Quthami Khalid, Fadel Qabani, Mazen G Saeedi, Fauziah F Abusaadh, Suliman A Esmat, Saeed A Badahdah

Clinical specificity and genotype/subtype detection of viruses using the Cobas TaqScreen MPX system V 2.0, which is a nucleic acid test (NAT) that uses multiples for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) strain variants, were investigated. The 95% LOD was employed in the experiment and the results returned a positive accuracy of 99.6%. which is consistent with the expected success rate as specified by Roche.

NAT, Multiplex, PCR

1. American Association of Orthopedic Surgeons. "Information Statement Preventing the Transmission of Bloodborne Pathogens." Preventing the Transmission of Bloodborne Pathogens. American Association of Orthopedic Surgeons, 1 Jan. 2014. Web. Accessed 6 Feb. 2015.
2. Cobuang, R., and L. Vinicci. "NRL EQAS: Observations from the NAT Blood Screening Program, 2012." NRL. NRL. Web. Accessed 6 Feb. 2015.
3. Health Canada "Summary Basis of Decision (SBD) for COBAS TAQSCREEN MPX TEST." Summary Basis of Decision: COBAS TaqScreen MPX Test. Health Canada, 9 Mar. 2010. Web. Accessed 6 Feb. 2015.
4. Jarvis, L, J Becker, A Tender, A Cleland, L Queiros, A Aquiar, J Azevedo, G Aprili, F Bressan, P Torres, S Nieto, A Ursitti, J Montoro, E Vila, C Ramada, and J Saldanha. Evaluation of the Roche Cobas S 201 System and Cobas Taqscreen Multiplex Test for Blood Screening: a European Multicenter Study. Transfusion. 48.9 (2008): 1853-61. Print http://dx.doi.org/10.1111/j.1537-2995.2008.01779.x
5. Labmedica "Test Screens Source Plasma for HIV, Hepatitis B, and Hepatitis C Virus” Labmedica.com. Lab Medica, 15 Dec. 2009. Web. Accessed 6 Feb. 2015.
6. Peterson, Brian R. New Developments in Blood Transfusion Research. New York: Nova Science Publishers, 2006. Internet resource
7. Roche Canada "Cobas ® TaqScreen MPX Test, Version 2.0 for Use on the Cobas S 201 System." Roche Canada. Roche Canada. Web. Accessed 6 Feb. 2015.
8. Saldanha, John. "Maximising Efficiency: IPFA/PEI 18th International Workshop on Surveillance and Screening of Blood Borne Pathogens."IPFA. IPFA, 11 May 2011. Web. Accessed 6 Feb. 2015
9. Schmidt, M, L Pichl, C Jork, MK Hourfar, V Schottstedt, FF Wagner, E Seifried, TH Müller, J Bux, and J Saldanha. "Blood Donor Screening with Cobas S 201/Cobas Taqscreen Mpx Under Routine Conditions at German Red Cross Institutes." Vox Sanguinis. 98.1 (2010): 37-46. Print http://dx.doi.org/10.1111/j.1423-0410.2009.01219.x
10. Wilson, Jennie. Infection Control in Clinical Practice. Edinburgh: Baillière Tindall/Elsevier, 2006. Print